To Study the Spread Curve of Corona Virus in India

Patnaik       Amit; Sinha       Anita; Oraon       Vinay; Srivastava    Anjani    Kumar; Kumar       Jyoti

Abstract

Background: Surprisingly, all the developed countries across the world are reeling under death due to the Coronavirus infection cases (COVID 19), but a developing country like India with the second largest population still here, the casualty is very less and recovery rate is very high due to the strong immunity of the people, vaccination regime for other diseases and hot and humid condition of the country.

Objective: Yet, the greatest number of cases are in the State of Maharashtra, Tamil Nadu, Delhi, Karnataka, Gujrat, Uttar Pradesh, and Telangana the Western, Central, and Southern part of the country surprisingly the Eastern part of the country have a less number of active cases and also the mortality except for West Bengal.

Conclusion: In the State of Jharkhand very less number of active cases i.e., 2785 and mortality is only 49, is there any role of geographical condition or there is some strong genetic form so that the inhabitants have very strong immune resistance to develop the infection initiated by the virus. In this review, these questions are in focus and may be solved.

Keywords: ACE2, India, COVID19, Jharkhand, heat, polymorphic.

Graphical Abstract

[1] 
Mace TA, Zhong L, Kilpatrick C, et al. Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. J Leukoc Biol  2011; 90(5): 951-62.
[http://dx.doi.org/10.1189/jlb.0511229] [PMID:  21873456] 
[2] 
National Center for Biotechnology Information (NCBI) US National Library of Medicine. Gene: ACE2, angiotensin I converting enzyme 2. Available from:. https://www.ncbi.nlm.nih. gov/gene/59272
[3] 
Lambert DW, Yarski M, Warner FJ, et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem  2005; 280(34): 30113-9.
[http://dx.doi.org/10.1074/jbc.M505111200] [PMID:  15983030] 
[4] 
Patel VB, Clarke N, Wang Z, et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol  2014; 66: 167-76.
[http://dx.doi.org/10.1016/j.yjmcc.2013.11.017] [PMID:  24332999] 
[5] 
Kuba K, Imai Y, Penninger JM. Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ J  2013; 77(2): 301-8.
[http://dx.doi.org/10.1253/circj.CJ-12-1544] [PMID:  23328447] 
[6] 
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol  2015; 1282: 1-23.
[http://dx.doi.org/10.1007/978-1-4939-2438-7_1] [PMID:  25720466] 
[7] 
Li F. Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res  2013; 100(1): 246-54.
[http://dx.doi.org/10.1016/j.antiviral.2013.08.014] [PMID:  23994189] 
[8] 
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med  2005; 11(8): 875-9.
[http://dx.doi.org/10.1038/nm1267] [PMID:  16007097] 
[9] 
WHO. What are the official names of the disease and the virus that causes it? Q A on coronaviruses World Health Organization Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub
[10] 
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature  2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID:  32015507] 
[11] 
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci  2020; 63(3): 457-60.
[http://dx.doi.org/10.1007/s11427-020-1637-5] [PMID:  32009228] 
[12] 
Lewis R. COVID-19 vaccine will close in on the spikes, DNA Science Blog Public Library of Science. Available from:. https://dnascience.plos.org/2020/02/20/covid-19-vaccine-will-close-in-on-the-spikes/
[13] 
Wang H, Yang P, Liu K, et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res  2008; 18(2): 290-301.
[http://dx.doi.org/10.1038/cr.2008.15] [PMID:  18227861] 
[14] 
Millet JK, Whittaker GR. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology  2018; 517: 3-8.
[http://dx.doi.org/10.1016/j.virol.2017.12.015] [PMID:  29275820] 
[15] 
Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol  2008; 93(5): 543-8.
[http://dx.doi.org/10.1113/expphysiol.2007.040048] [PMID:  18448662] 
[16] 
Jia H. Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and inflammatory lung disease. Shock  2016; 46(3): 239-48.
[http://dx.doi.org/10.1097/SHK.0000000000000633] [PMID:  27082314] 
[17] 
Nicholls J, Peiris M. Good ACE, bad ACE do battle in lung injury, SARS. Nat Med  2005; 11(8): 821-2.
[http://dx.doi.org/10.1038/nm0805-821] [PMID:  16079870] 
[18] 
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol  2020; 94(7): e00127-20.
[http://dx.doi.org/10.1128/JVI.00127-20] [PMID:  31996437] 
[19] 
Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the reninangiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res 2017; 125(Pt A): 21-38.. 
[http://dx.doi.org/10.1016/j.phrs.2017.06.005] [PMID: 28619367] 

Cite As